Mesa Laboratories, Inc.
MLAB
$125.73
$3.402.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.68% | 6.88% | 2.02% | -1.32% | -4.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.68% | 6.88% | 2.02% | -1.32% | -4.27% |
| Cost of Revenue | 4.46% | -0.90% | -3.42% | -3.83% | -2.79% |
| Gross Profit | 16.30% | 11.96% | 5.52% | 0.28% | -5.19% |
| SG&A Expenses | 1.33% | 5.96% | 5.61% | 2.62% | -1.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.68% | 2.30% | 1.26% | -0.73% | -2.35% |
| Operating Income | 6,994.16% | 308.26% | 24.44% | -39.76% | -106.69% |
| Income Before Tax | -45,402.87% | -42,543.50% | -6,727.66% | -70,760.67% | -275.32% |
| Income Tax Expenses | -1,223.10% | -21,395.74% | -1,004.15% | -1,522.59% | -217.90% |
| Earnings from Continuing Operations | -26,412.55% | -34,160.95% | -13,860.80% | -27,438.28% | 164.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26,412.55% | -34,160.95% | -13,860.80% | -27,438.28% | 164.71% |
| EBIT | 6,994.16% | 308.26% | 24.44% | -39.76% | -106.69% |
| EBITDA | 26.51% | 9.76% | -6.08% | -7.90% | -12.74% |
| EPS Basic | -26,360.65% | -34,455.31% | -13,672.83% | -27,600.29% | 162.36% |
| Normalized Basic EPS | 479.17% | 1,151.69% | -79.53% | -249.52% | -149.29% |
| EPS Diluted | -27,716.36% | -31,870.11% | -14,273.25% | -30,125.22% | 156.26% |
| Normalized Diluted EPS | 470.79% | 1,132.59% | -79.58% | -226.61% | -150.62% |
| Average Basic Shares Outstanding | 0.61% | 0.70% | 0.88% | 1.23% | 1.48% |
| Average Diluted Shares Outstanding | 0.85% | 0.86% | 0.58% | 0.80% | 1.35% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -1.00% | 1.00% | -1.01% | -1.00% | 2.57% |
